Harłozińska A, Bar J K, Jothy S, Sedlaczek P, Slesak B, Richter R
Department of Tumor Immunology, Silesian Piast's Medical Academy, Wrocław, Poland.
Tumour Biol. 1993;14(1):1-8. doi: 10.1159/000217819.
The aim of this study was to establish whether different subsets of ovarian neoplasms express a restricted isotype of carcinoembryonic antigen (CEA) which can be detected in solid tumors and detached cells. Sixty-one cases of mucinous, serous, endometrioid, and Krukenberg tumors were studied by immunohistochemistry using two monoclonal antibodies (MAbs), commercial anti-CEA and D14 with a higher specificity for colorectal adenocarcinomas. The results with both antibodies showed a considerable degree of heterogeneity between cases of nonserous tumors, with a more restrictive pattern observed with the D14 MAb. The proportion of immunostained cells was comparable in tumors and fluids.
本研究的目的是确定卵巢肿瘤的不同亚群是否表达一种在实体瘤和脱落细胞中可检测到的癌胚抗原(CEA)受限同种型。使用两种单克隆抗体(MAb),即市售抗CEA和对结肠腺癌具有更高特异性的D14,通过免疫组织化学对61例黏液性、浆液性、子宫内膜样和库肯勃瘤进行了研究。两种抗体的结果均显示非浆液性肿瘤病例之间存在相当程度的异质性,D14单克隆抗体观察到的模式更为受限。肿瘤和体液中免疫染色细胞的比例相当。